The Rockefeller Foundation Bruce Gellin on Vaccination Inequity

00:00Although more than 3 billion people have been vaccinated, it seems that there is still a large gap between the haves versus the have-nots. This is true. Nearly three billion doses have been administered, as you mentioned. The majority of high-income countries are actually meeting with the World Health Organization. They pointed out that there is a 60 foot 60-fold difference in vaccination rates and high-end countries versus low-income countries. This could pose a serious risk to developing countries. We will continue to find out how these vaccines work. We know so far that those who have been well vaccinated are protected from these variants. This pandemic will continue to spread if we don't get better vaccination. Dr. Galan, how can you bridge the gap between these richer and poorer nations? It is up to the richer countries to give more. There are many things that need to be done. You are right. This is a critical issue. There is an increase in vaccine production worldwide. This means that the vaccine needs to be moved to other countries quickly. It can be done in many ways. Sharing is the best way to start. Some of this has been seen with the G7. We need more. We need more donations. Sharing is going to be an important thing in the short term. How easy it is to increase existing manufacturing. Existing producers can produce more. However, we are also trying to increase global vaccineproduction here and around the globe. We also want regional manufacturing. It will take some time, but we are going to get started. We also know this will be expensive. This has been a topic of discussion for a while. It's not only the vaccine we need. It is important to ensure that vaccinations do not save lives when the vaccine becomes vaccines. Vaccinations save lives. We need to ensure that vaccines are quickly and fairly distributed in countries. Yes, we are seeing the hesitancy in Hong Kong. You mentioned India, which is a very personal story for Rockefeller Foundation. How are they managing this pandemic? What lessons can we draw from it? One of the most important lessons we can learn from this pandemic is to be open to learning from others. Pandemic Preparedness Institute was recently announced by TheRockefeller. This institute is working hard to try to understand the data they produce. We can respond faster if we find them sooner. This is just one of the pieces. We also have to be able fund the vaccination programs. Working with other people, we have identified special drawing rights from the IMF that would allow usto reserve funds to be able to fund some of these programs. This is a critical need right now, as we need to control the pandemic and make sure we don't have any more. Could SDR special drawings rights be a game-changer? DAX a gallon. While we talk a lot about vaccination, we must be able and willing to fund it all. That's what's going be an important part. It's an important step in financing what we need. The supply is the key. We need to ensure that we can distribute the supply to countries that are in greatest need, and that we have more equity equity than we currently have. Financing is going to be a crucial part of that. What about a patent waiver? That is something we all know. Yes, I think people are divided about whether or not that would work. How do you feel about that? That's a fair amount of the playing field. It is possible, but not necessarily immediately. The key to technology transfer is I believe. We've been talking a lot about MRSA, but there are many other promising technologies. To be able move these technologies to other regions and build the facilities needed. Patent waivers are a part of this. This isn't going to solve the problem immediately. To be able produce vaccines in a safe and fair manner, we need to plan how these facilities can be organized around the globe. Last question, not a gallon of Kovacs. The goal is to secure two billion doses of medication to poorer countries by the end of this year. However, there seems to be some gap due to delays in manufacturing and disruptions that we have seen in India. What progress have you seen to date? Do you believe you can actually achieve this goal? You are correct. Kovacs had high aspirations. To date, they have had many offrustrations due to the reasons you mentioned. They have contracts that will allow them to start delivering vaccines, but they also have the ability to absorb vaccines from other countries and redistribute them. We'll be seeing this more over the third and fourth quarters.